Equities analysts expect MedEquities Realty Trust Inc (NYSE:MRT) to announce earnings of $0.31 per share for the current quarter, according to Zacks. Three analysts have made estimates for MedEquities Realty Trust’s earnings, with the highest EPS estimate coming in at $0.31 and the lowest estimate coming in at $0.30. MedEquities Realty Trust posted earnings of $0.29 per share in the same quarter last year, which suggests a positive year-over-year growth rate of 6.9%. The business is scheduled to report its next quarterly earnings report on Tuesday, November 6th.
On average, analysts expect that MedEquities Realty Trust will report full year earnings of $1.19 per share for the current financial year, with EPS estimates ranging from $1.14 to $1.23. For the next fiscal year, analysts expect that the firm will post earnings of $1.20 per share, with EPS estimates ranging from $1.15 to $1.25. Zacks’ earnings per share averages are an average based on a survey of analysts that that provide coverage for MedEquities Realty Trust.
MedEquities Realty Trust (NYSE:MRT) last issued its earnings results on Wednesday, August 8th. The financial services provider reported $0.10 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.30 by ($0.20). The company had revenue of $17.56 million for the quarter, compared to analysts’ expectations of $17.03 million. MedEquities Realty Trust had a net margin of 30.84% and a return on equity of 5.73%.
Shares of MRT traded down $0.22 during trading hours on Friday, reaching $8.74. 2,439 shares of the company traded hands, compared to its average volume of 153,085. The firm has a market capitalization of $309.70 million, a P/E ratio of 7.86 and a beta of -0.07. MedEquities Realty Trust has a 12-month low of $8.63 and a 12-month high of $12.04.
In related news, Director Bluemountain Capital Managemen sold 21,289 shares of the company’s stock in a transaction dated Monday, October 15th. The shares were sold at an average price of $8.80, for a total value of $187,343.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Over the last ninety days, insiders sold 66,112 shares of company stock valued at $594,325. 3.00% of the stock is owned by insiders.
A number of institutional investors have recently made changes to their positions in the business. American Century Companies Inc. raised its holdings in MedEquities Realty Trust by 3.2% in the second quarter. American Century Companies Inc. now owns 2,171,911 shares of the financial services provider’s stock worth $23,934,000 after purchasing an additional 66,695 shares in the last quarter. BlackRock Inc. raised its holdings in MedEquities Realty Trust by 5.5% in the second quarter. BlackRock Inc. now owns 1,499,494 shares of the financial services provider’s stock worth $16,526,000 after purchasing an additional 77,884 shares in the last quarter. Russell Investments Group Ltd. raised its holdings in MedEquities Realty Trust by 10.8% in the first quarter. Russell Investments Group Ltd. now owns 1,165,213 shares of the financial services provider’s stock worth $12,246,000 after purchasing an additional 113,799 shares in the last quarter. Renaissance Technologies LLC raised its holdings in MedEquities Realty Trust by 36.0% in the second quarter. Renaissance Technologies LLC now owns 839,800 shares of the financial services provider’s stock worth $9,255,000 after purchasing an additional 222,500 shares in the last quarter. Finally, Eagle Boston Investment Management Inc. raised its holdings in MedEquities Realty Trust by 4.5% in the second quarter. Eagle Boston Investment Management Inc. now owns 782,861 shares of the financial services provider’s stock worth $8,627,000 after purchasing an additional 33,834 shares in the last quarter. Institutional investors and hedge funds own 90.80% of the company’s stock.
About MedEquities Realty Trust
MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.
See Also: What Does Beta Mean In Stock Selection
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.